Sandra Horning speaks at an Endpoints News event during the #JPM19 healthcare conference (Jeff Rumans for Endpoints News)
September 6, 2019 06:41 AM EDT
R&D
Pharma

Roche boosts can­cer ap­provals in Eu­rope, push­ing for a big­ger slice of the I/O pie

Natalie Grover

Reporter

Roche is stack­ing up ap­provals for its flag­ship check­point in­hibitor in the lu­cra­tive field of lung can­cer. On Fri­day, the Swiss drug­mak­er re­vealed that the …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

David Ep­stein gets $140M for Ot­ti­mo's bi­func­tion­al take on hot PD-1xVEGF field

Roche’s Parkin­son’s drug flunks sec­ond mid-stage tri­al

No­var­tis turns to BioAge for new tar­gets based on longevi­ty and ex­er­cise

Sang­amo strikes an­oth­er brain-tar­get­ing AAV part­ner­ship, this time with Astel­las

Mer­ck’s long-await­ed obe­si­ty move is an oral GLP-1 from Chi­na

A service from the Financial Times